AWM
NVAX icon

AE Wealth Management’s Novavax NVAX Stock Holding History

AE Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,266
Closed -$388K – 1796
2022
Q1 		$388K Buy
5,266
+2,224
+73% +$198K ﹤0.01% 1315
2021
Q4 		$435K Buy
3,042
+887
+41% +$152K ﹤0.01% 1299
2021
Q3 		$447K Buy
2,155
+392
+22% +$86.4K ﹤0.01% 1211
2021
Q2 		$374K Buy
1,763
+621
+54% +$114K ﹤0.01% 1250
2021
Q1 		$207K Sell
1,142
-5,535
-83% -$1.1M ﹤0.01% 1396
2020
Q4 		$745K Buy
6,677
+3,034
+83% +$322K 0.01% 809
2020
Q3 		$395K Buy
3,643
+829
+29% +$101K 0.01% 949
2020
Q2 		$235K Buy
+2,814
New +$108K ﹤0.01% 1109

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AE Wealth Management's NVAX Position: Q2 2022 in Review

AE Wealth Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 5,266 shares — an estimated $388K sold.

AE Wealth Management first reported a position in NVAX in Q2 2020 and held it in 8 quarters. The position peaked at $745K in Q4 2020. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • AE Wealth Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • AE Wealth Management sold 5,266 Novavax shares in Q2 2022, an estimated $388K.
  • AE Wealth Management first reported a position in Novavax in Q2 2020 and held it in 8 quarters.
  • AE Wealth Management's Novavax position peaked at $745K in Q4 2020.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on AE Wealth Management's 13F filing for Q2 2022, filed 3 Aug 2022.